At the 2019 ASCRS, Professor Zadok presented the initial results from EpiTech’s 1st pilot study treating a total of 15 patients.

As presented by Prof. Zadok, the initial results are extremely promising and the effect of ocular magnetic neurostimulation demonstrate clinically significant improvement in both signs and symptoms. The pilot study is due to continue, treating additional patients.